Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | THRA | P10827 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22304761 | 0.89 | MAPT (0.45) | MAPTL3MBTL1HTTPKMGAA | |
| SCHEMBL12994174 | 0.87 | L3MBTL1 (0.47) | MAPTL3MBTL1HTTPOLBLMNA | |
| SCHEMBL3680765 | 0.86 | MAPT (0.43) | MAPTL3MBTL1HTTPKMGAA | |
| SCHEMBL3372714 | 0.86 | MAPT (0.46) | MAPTL3MBTL1HTTPOLBRAB9A | |
| SCHEMBL2384863 | 0.86 | L3MBTL1 (0.45) | MAPTL3MBTL1HTTPKMGAA | |
| SCHEMBL12328386 | 0.86 | MAPT (0.43) | MAPTL3MBTL1HTTPKMGAA | |
| SCHEMBL3975588 | 0.85 | L3MBTL1 (0.47) | MAPTL3MBTL1PKMGAARAB9A | |
| SCHEMBL24141546 | 0.85 | MAPT (0.42) | MAPTL3MBTL1HTTPKMGAA | |
| SCHEMBL12994172 | 0.85 | PKM (0.53) | MAPTL3MBTL1PKMPOLBRAB9A | |
| SCHEMBL12799434 | 0.84 | HTT (0.56) | MAPTL3MBTL1HTTPKMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791289-B2 | Preparation method of copolymerizable photoinitiators | AGFA GRAPHICS NV (BE) | 2014-07-29 | — | — | US | disclosed |
| US-8791289-B2 | Preparation method of copolymerizable photoinitiators | AGFA GRAPHICS NV (BE) | 2014-07-29 | — | — | US | disclosed |
| US-8664431-B2 | Preparation method of copolymerizable photoinitiators | AGFA GRAPHICS NV (BE) | 2014-03-04 | — | — | US | disclosed |
| US-8664431-B2 | Preparation method of copolymerizable photoinitiators | AGFA GRAPHICS NV (BE) | 2014-03-04 | — | — | US | disclosed |
| US-20140024840-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | AGFA GRAPHICS NV (BE) | 2014-01-23 | — | — | US | disclosed |
| US-20140024840-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | AGFA GRAPHICS NV (BE) | 2014-01-23 | — | — | US | disclosed |
| US-20100305336-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | AGFA GRAPHICS NV (BE) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305336-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | HBB, HBZ, HBG1 | MAPT 4314/4885L3MBTL1 935/4885HTT 1277/4885 |
| US-20140024840-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | HBB, HBZ, HBG1 | MAPT 4435/4885L3MBTL1 1025/4885HTT 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.